)
Edge31 Oct 2025
Rolls-Royce: Full Thrust Ahead
From century-old crafted perfection to pandemic shock and reset, Rolls-Royce's story is shaped by heritage, turbulence, and a disciplined climb back.
Aurobindo Pharma (AUROPHARMA) investor relations material
Aurobindo Pharma Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary6 Nov, 2025
Executive summary
Q2 FY2026 consolidated revenue grew 6.3% year-over-year to ₹8,286 crore, driven by strong U.S., European, and growth market performance.
EBITDA rose 7% year-over-year to ₹1,678 crore, with a margin of 20.3%, reflecting operational efficiencies and stable gross margins.
Net profit for the quarter was ₹848 crore, a 3.8% increase year-over-year.
Free cash flow before dividend and buybacks was $57 million, with a net cash position of $170 million as of September 2025.
Standalone and consolidated unaudited financial results for Q2 and H1 FY2026 were approved and reviewed without qualification by auditors.
Financial highlights
Formulation business revenue grew 10% year-over-year to ₹7,325 crore, accounting for 88% of total revenue.
API business contributed 12% of revenue at ₹961 crore, though it declined 16.9% year-over-year.
U.S. revenues reached $417 million, with 6% quarter-on-quarter growth in injectables.
European revenue grew 18% year-over-year to ₹2,480 crore (EUR 243 million).
ARV formulation revenue surged 69% year-over-year to ₹325 crore.
Gross margin improved to 59.7% from 58.8% last quarter.
R&D expenditure was ₹414 crore, 5% of revenue.
Reported EPS rose to ₹14.61, a 4.4% increase year-over-year.
Outlook and guidance
Confident in sustaining growth momentum, with volume expansion and stable pricing expected.
U.S. site launches scheduled from January, with significant revenue contribution expected in FY 2027.
OSG China facility on track for EBITDA break-even by Q3-Q4 FY2026.
Strategic focus on accelerating biosimilars pipeline post-2028 and investing in manufacturing capacity.
Plans for new product launches and expansion into additional geographies.
Cash flow from operations surged. Detail key drivers.
Note 6 mentions Lannett acquisition. Strategic rationale?
51 subsidiaries' financials were unreviewed. Why?
Penngi MIP: What is the full scope of products?
US biosimilar filing sequence and rationale?
US injectables: New product pipeline beyond UGF3?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Aurobindo Pharma earnings date
Q3 202614 Feb, 2026
Next Aurobindo Pharma earnings date
Q3 202614 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Aurobindo Pharma Limited is an Indian pharmaceutical company engaged in the research, development, manufacturing, and marketing of a wide range of generic medicines. The company’s product portfolio includes antibiotics, antiretrovirals, cardiovascular drugs, central nervous system agents, gastroenterology products, and anti-allergics, among others. Aurobindo Pharma serves markets globally, supplying generic pharmaceuticals to hospitals, pharmacies, and healthcare providers. The company also produces active pharmaceutical ingredients (APIs) and has expanded into specialty drugs and biosimilars. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage